Psychiatry · Philadelphia, PA
NPI
1447359179
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
601 Walnut St, Suite 960w
Philadelphia, PA, 19106
Phone (215) 592-7852
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$141K
2,334 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Steven Zavodnick prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 224 prescriptions and refills. In total Steven Zavodnick wrote 2,334 Medicare prescriptions that cost $141K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Bupropion Xl Bupropion Hcl | 224 | 433 | 45 | $4,517 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 202 | 428 | 41 | $3,749 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 183 | 196 | 31 | $5,189 |
| Clonazepam Generic | 174 | 234 | 31 | $1,592 |
| Lamotrigine Generic | 137 | 303 | 30 | $2,565 |
| Duloxetine Hcl Generic | 121 | 236 | 23 | $2,338 |
| Trazodone Hcl Generic | 117 | 192 | 26 | $1,184 |
| Alprazolam Generic | 99 | 149 | 20 | $519 |
| Buspirone Hcl Generic | 86 | 169 | 18 | $1,503 |
| Escitalopram Oxalate Generic | 73 | 182 | 21 | $1,111 |
| Lorazepam Generic | 65 | 102 | 17 | $466 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 57 | 65 | Under 11 | $5,291 |
| Quetiapine Fumarate Generic | 56 | 104 | 13 | $1,004 |
| Bupropion Hcl Sr Bupropion Hcl | 55 | 71 | Under 11 | $770 |
| Aripiprazole Generic | 44 | 80 | Under 11 | $1,698 |
Brand drugs: 120 claims; generic drugs: 2,214 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Steven Zavodnick were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.